Liu, P., Zhao, L., Loos, F., Iribarren, K., Kepp, O., & Kroemer, G. (2018). Epigenetic anticancer agents cause HMGB1 release in vivo. Oncoimmunology.
Chicago Style CitationLiu, Peng, Liwei Zhao, Friedemann Loos, Kristina Iribarren, Oliver Kepp, i Guido Kroemer. "Epigenetic Anticancer Agents Cause HMGB1 Release in Vivo." Oncoimmunology 2018.
Cita MLALiu, Peng, et al. "Epigenetic Anticancer Agents Cause HMGB1 Release in Vivo." Oncoimmunology 2018.
Atenció: Aquestes cites poden no estar 100% correctes.